Hereditary angioedema (HAE) is a potentially life-threatening genetic disorder characterized by recurrent swelling attacks.

Resources are available to help physicians when they encounter variants of unknown significance during genetic testing, Troy ...

Pharming Group (PHGUF) reports a 42% revenue increase, driven by Ruconest and Joenja sales, while navigating acquisition costs and potential tariff challenges.

Q1 2025 Earnings Conference Call May 8, 2025 7:30 AM ETCompany ParticipantsFabrice Chouraqui – CEOStephen Toor – ...

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, ref ...

RUCONEST® demonstrated significant strength in the first quarter of 2025, with revenues of US$68.6 million, a 49% increase compared to the first quarter of 2024. The U.S. market contributed 97% of ...

Stress, affecting a significant portion of the Indian population, isn't solely environmental; genetics play a role in how individuals react. Endophenotypes influence emotional sensitivity ...

She has the most common fatal genetic disease in the U.S., which afflicts 40,000 Americans. But her case is caused by a rare genetic mutation, so medications that work for 90% of people with ...

Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Company’s 2025 Annual General ...

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director Pharming Group N.V. Wed, Apr 30, 2025, 8:45 AM 3 min read ...

(MENAFN- GlobeNewsWire - Nasdaq) Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming” or“the Company”) (Euronext Amsterdam: PHARM / Nasdaq ...

The paper co-authored by Bicknell, recently published in Nature Reviews Genetics, highlights the many ways health and height are linked. Bicknell, an expert in rare disorders of growth ...